| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |